Camden National Corporation’s Johnson & Johnson JNJ Stock Holding History

Camden National Corporation’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$10.3M	Buy	+62,785	New	+$10.2M	2.06%	11

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Camden National Corporation's JNJ Position: Q1 2021 in Review

Camden National Corporation opened a new position in Johnson & Johnson (JNJ) in Q1 2021: 62,785 shares worth $10.3M. The stake represents 2.06% of the portfolio and ranks #11 among its holdings.

3,317 funds tracked by Wall St. Rank hold JNJ as of Q1 2021.

Camden National Corporation held 62,785 shares of Johnson & Johnson worth $10.3M as of Q1 2021.
Johnson & Johnson was a new Camden National Corporation position in Q1 2021.
Johnson & Johnson made up 2.06% of Camden National Corporation's portfolio in Q1 2021, its #11 holding.
3,317 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.